Study Status: No longer available
Recruit Status: No longer available
Study Type: Expanded Access: Available for Individual Patients
Official Title: Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)
Brief Summary: A subject was treated under compassionate use provisions under this study with facilitating cell therapy (FCRx) product manufactured using the CliniMACS (Miltenyi Biotec) device, rather than the Max Sep (Baxter) device.